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http:WHAT THIS PAPER ADDS
This study reports ulcer healing outcomes following deep vein stenting. It will guide decision makers in treat-
ment choices for venous ulcer management.Objective: To report the outcomes of endovascular interventions on deep veins in patients with venous ulcers
(C6).
Methods: This was a retrospective review of a case series. All patients with active venous ulceration who
underwent endovascular interventions to the deep venous system from February 2011 to June 2013 were
included. Patients with C6 disease who failed a trial of adequate compression therapy or superﬁcial vein
interventions were considered for evaluation of the deep veins. Patients with deep vein reﬂux or without
signiﬁcant venous reﬂux or with a previous history of deep vein thrombosis underwent computed tomographic
venogram or ascending venogram. In the absence of intravenous ultrasound trial ballooning to look for a “waist”
to identify subtle lesions was used. Lesions were stented with long Nitinol stents.
Results: Thirty-eight patients underwent deep vein stenting of 44 limbs with venous ulcers. The lesions were
considered to be post-thrombotic in 31 limbs and non-thrombotic iliac vein lesions in 13 limbs. A mean of 1.8
stents were used per patient. There were no signiﬁcant complications associated with the interventions. At a
median follow-up of 15 months, the primary and assisted primary patency rates were 94% and 97%, respectively.
Sustained ulcer healing was achieved in 60% of limbs. A further 20% of ulcers had reduced in size. Recurrent
ulcers developed in 13% of limbs, and half of these healed with interventions for newly developed incompetence
in superﬁcial veins.
Conclusion: Endovascular interventions to the deep veins appear to be an effective adjunct in achieving the
healing of recalcitrant ulcers.
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Venous ulcerINTRODUCTION
Venous ulcers are a common and recalcitrant problem. The
estimated prevalence of active venous ulcers is 0.8e1.0 per
1000 population.1 The mainstay of management has been
compression therapy with or without interventions to cor-
rect superﬁcial venous reﬂux.2,3 However, all strategies are
known to be associated with a recurrence rate of 25e56%
in the longer term.4
In the past, persistent ulcers have been addressed by
repair or transposition of deep vein valves with good suc-
cess.5 The contribution of obstructive disease within the
deep venous system in the development of venous stasis
ulcers has been largely ignored. Work from a few centers
has highlighted its relevance in the development of the
features of venous insufﬁciency,6,7of original article: http://dx.doi.org/10.1016/j.ejvs.2014.05.016
responding author.
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//dx.doi.org/10.1016/j.ejvs.2014.04.031The aim of the current study was to report experience
with the stenting of deep veins in patients with persistent
venous ulcers.
MATERIAL AND METHODS
This was a retrospective review of prospectively collected
data.Study group
Patients with active venous ulcers attending the outpatient
clinics of the Narayana Institute of Vascular Sciences during
the period February 2011eJune 2013 were evaluated for
venous insufﬁciency.Assessment
In addition to taking a thorough history and physical ex-
amination, all patients underwent duplex ultrasound (US)
evaluation of the superﬁcial and deep venous systems of
the affected limb. Incompetence was deﬁned as the pres-
ence of reverse ﬂow in the femoral vein lasting >1 s after
Figure 1. Non-thrombotic iliac vein lesion before and after stent-
ing. Note degree of stent extension within the inferior vena cava.
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popliteal junctions and saphenous trunks lasting >0.5 s.8
Patients with superﬁcial reﬂux were offered endovenous
ablation with compression therapy, and others were treated
with compression therapy alone. Patients who failed an
adequate trial of compression therapy or who had a
persistent ulcer despite successful abolition of superﬁcial
reﬂux underwent assessment of the deep venous system by
contrast-enhanced computed tomographic (CT) venogram.
CT venogram images were reviewed for telltale signs of
deep venous pathology. CT characteristics of deep venous
obstruction were the absence or narrowing of the vein, and
discrepancy in bilateral vein diameters. A reduced diameter
was considered suggestive of ﬁbrosis and an increased
diameter was suggestive of pre-stenotic dilatation, the
presence of signiﬁcant pelvic or axial collaterals, or visible
compression of the iliac vein by overlying arterial structures.
Enlargement and prominence of the deep femoral vein,
especially in comparison with the opposite side, was
assessed at the same time. Patients with the features of
deep vein obstruction on CT venogram underwent
ascending venography and intervention, if appropriate.
Interventional techniques
All procedures were performed under local anesthesia
supplemented with intravenous analgesia and sedation
when required. This was most often at the time of trial
ballooning or therapeutic angioplasty or stenting.
Ascending venogram was performed by US-guided
percutaneous puncture of a normal segment of vein
caudad to the presumed site of disease, most commonly
the common femoral vein through a 6-Fr sheath. Images
were acquired with a contralateral 20 oblique view for the
iliacs and 20 ipsilateral oblique view for the femoral vein. If
normal, images were acquired in a projection of 90 to the
original plane.
When the common femoral vein (CFV) was assessed as
being disease-free it was the preferred site for access. For
patients with diseased femoral veins but well developeddeep femoral veins, access was obtained through the
normal section of femoral vein or popliteal or small
saphenous vein (SSV).Where the deep femoral vein was not
well developed, access was always obtained through the
popliteal or SSV with the patient prone.
Compression or narrowing is not considered to be the
only sign of venous obstruction; other features were also
considered.9 Features suggestive of iliac vein obstruction
were occlusion, stenosis, abnormal collaterals, layering of
contrast, holdup and non-clearance of contrast, ﬁlling de-
fects, and axial or cross-pelvic collaterals. Fig. 1 shows the
venographic appearance of an NIVL lesion before and after
stenting
Lesions were classiﬁed as being likely post-thrombotic or
non-thrombotic iliac vein lesions (NIVL) according to their
venographic features. Discrete areas of abnormality at sites
described for proximal and distal NIVL were classiﬁed as
NIVL. Non discrete lesions and lesions in patients with a
history of deep vein thrombosis (DVT) were classiﬁed as
post-thrombotic.
Unfractionated heparin (80 IU/kg) was administered and
the lesion crossed using a combination of an angled cath-
eter with a 0350 hydrophilic wire. Once across the lesion,
the hydrophilic wire was exchanged for a stiff J tip 0350
guidewire (Emerald; Cordis, Bridgewater, NJ, USA).
In the absence of clearly visualized occlusions or stenosis,
“trial angioplasty” was performed. The 6-Fr sheath was
exchanged for a 9-Fr one compatible with 12e14-mm bal-
loons (Atlas, Bard Peripheral Vascular, Tempe, AZ, USA; and
Maxi LD, Cordis). A 14-mm (common iliac vein [CIV]) or a
12-mm balloon (external iliac vein [EIV]) was inﬂated until it
achieved a smooth cylindrical shape or a pressure of 1 at-
mosphere. under ﬂuoroscopic guidance. The presence of a
“waist” during this process was considered to be diagnostic
of a stenosis.
All stenotic and occlusive lesions were treated by
stenting. For signiﬁcantly stenotic or occlusive lesions pre-
dilation with smaller diameter balloons was performed ﬁrst.
Self-expanding Nitinol stents were used preferentially. For
inferior vena cava (IVC) lesions, large-diameter (16e24 mm)
Niti stents (Taewoong Medical, Seoul, Korea) were used. E-
Luminexx stents (Bard Peripheral Vascular) were used for
common iliac lesions of 12e14 mm diameter, external iliac
lesions of 10e12 mm, common femoral lesions of 8e
10 mm diameter, and femoral vein lesions of 6e8 mm
diameter. Where multiple stents were used extensive
overlap was avoided ensuring that no areas were left
uncovered.
Long stents were used with the aim of covering the
visible lesion and also a minimum of 2e3 cm proximal and
distal to the lesion. For common iliac lesions the cranial end
of the stent was extended well into the IVC.
In the case of bilateral disease, the stents were deployed
by a kissing technique with the creation of a double barrel
of stents in the IVC. If required, the external iliac stent was
extended across the inguinal ligament to reach a healthy
inﬂow segment. All stents were post-dilated to their nom-
inal diameters and checked via venograms to conﬁrm an
Table 1. Clinical and ultrasound data.
Patients (n) 38
Sex (F:M) 1:2.1
Age in years (median) 25e67 (45)
History of DVT (n) 7
Duration of ulceration, mo (median) 1e120 (36)
Limbs involved (n) 44
332 R. George et al.adequate ﬂow. Improved diameter with good washout of
contrast from the stented area, the disappearance of col-
laterals, the absence of ﬁlling defects, dye stasis, and
layering were treated as successful end points.
Sheaths were removed in the angiosuite and local
compression applied.Right only (n) 13
Left only (n) 19
Bilateral ulceration (n) 6
Previous venous procedures in limbs (n) 13
High ligation with stripping (n) 9
Femoro-caval bypass graft (n) 1
EVLT (n) 1
IVC ﬁlter (n) 1
IVC stent (n) 1
Venous duplex ultrasound ﬁndings Present Absent
Deep venous reﬂux (femoral vein) 8 23
Signiﬁcant SFJ reﬂux 3 28
Signiﬁcant SPJ reﬂux 0 31
Perforator incompetence 28 3
Note. F ¼ female; M ¼ male; DVT ¼ deep vein thrombosis;
EVLT ¼ endovenous laser treatment; IVC ¼ inferior vena cava;
SFJ ¼ saphenofemoral junction; SPJ ¼ saphenopopliteal junction.Postoperative management and follow-up
In the absence of contraindications all patients were started
on therapeutic anticoagulation with low molecular weight
heparin (LMWH) within 6 h of sheath removal.
Patients were discharged the next morning on warfarin
with LMWH cover until an international normalized ratio
(INR) of >2 was achieved (target INR 2e3). Below-knee
stockings providing 23e32 mmHg of compression (Sigva-
ris, Winterthur, Switzerland) were applied over a parafﬁn
gauze dressing. Patients were advised to wear them 24 h a
day. Fig. 2 illustrates the ulcer outcomes during follow up.
Patients were advised to attend follow-up at 6 weeks, 3
months, and annually thereafter for clinical assessment.
Ulcers were assessed clinically with regard to whether they
had healed (i.e., completely epithelialized, reduced in size,
remained the same, recurred, or increased in size).
Where possible, duplex US examination was carried out
to conﬁrm stent patency at 6 weeks and 3 months, and
thereafter at 3-monthly intervals until 2 years after surgery.
Unless there was an underlying pro-thrombotic condition
requiring continued warfarin use, it was stopped at 3
months. All other patients were advised to continue on low-
dose aspirin indeﬁnitely at 75 mg once daily.
Patients living overseas or far from the hospital were
followed up by telephone and email with the assistance of
clinical photographs. Attempts were made to contact all
patients immediately prior to publication of this article.
All patients were advised to contact the hospital urgently
in the event of developing any leg swelling or pain.Statistical analysis
Data were entered into an Excel spreadsheet (Microsoft,
Redmond, WA, USA) and exported to SPSS version 15.0
(IBM, Armonk, NY, USA) for analysis. The outcomes were
assessed in three groups: ulcer-free, ulcer-persistent, and
ulcer-recurrent. The proportions of risk factors associated
with outcome were assessed using Fisher’s test. A p-Figure 2. Clinical evolution of lesions tvalue < .05 was considered signiﬁcant. A KaplaneMeier
analysis for ulcer outcomes for all patients and also for
those who achieved ulcer healing was carried out.
RESULTS
During the study period, 38 patients underwent stenting of
the deep venous system because of the presence of venous
ulcers in 44 lower limbs. The clinical data are presented in
Table 1.
Procedure details
All procedures were completed under local anesthesia with
percutaneous access. Percutaneous access was obtained
through CFV and femoral vein in 26 and seven patients,
respectively. Access was obtained through the small
saphenous or popliteal veins in ﬁve patients. In three pa-
tients with unilateral iliac vein occlusions, the contralateral
CFV was accessed to acquire a roadmap of the iliac
conﬂuence and IVC. In three patients with IVC occlusions,
additional access was obtained from right IJV.reated with deep venous stenting.
Table 2. Distribution of vein lesions (n) by region.
Region stented Stenosis Occlusion
IVC only 1 0
CIV only 12 0
EIV only 1 0
CFV only 0 0
FV only 2 0
IVC þ CIV 2 1
IVC þ CIV þ EIV 6 0
IVC þ CIV þ EIV þ CFV 2 1
CIV þ EIV 12 2
CIV þ EIV þ CFV 2 0
EIV þ CFV 0 0
Note. IVC ¼ inferior vena cava; CIV ¼ common iliac vein;
EIV ¼ external iliac vein; CFV ¼ common femoral vein;
FV ¼ femoral vein.
Table 3. Ulcer-related outcomes.
Follow up (%) 6 weeks (n ¼ 37) 15 months (n ¼ 35)
Healed 22 (59.4) 18 (51.4)
Reduced 11 (29.7) 7 (20.0)
Unchanged 4 (10.8) 4 (11.4)
Recurred
and healed
0 3 (8.5)
Recurred
and persistent
0 3 (8.5)
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post-thrombotic in 31. Four patients had complete occlu-
sions and 34 had stenotic lesions.
The distribution of stented regions, and of stenosis and
occlusions is shown in Table 2. The stented regions corre-
spond with the distribution of pathology and the CIVeEIV
segment was the most commonly covered. A mean of 1.8
stents was used per patient.
The stents were extended across the inguinal ligament in
ﬁve limbs.
The stents ranged from 40 mm to 120 mm in length. The
most commonly used stents were the 14  100 mm andTable 4. Statistical analysis of impact of variables on achieving ulcer-f
Ulcer-free at 15 mo Ulcer recurrence at 15 m
History of DVT 5 5
Previous superﬁcial
vein surgery
6 1
Deep vein reﬂux 4 2
SFJ or GSV reﬂux 5 5
SPJ or SSV reﬂux 3 1
3 incompetent
perforators
7 7
Occlusion 2 1
Post-thrombotic 13 7
NIVL 6 2
Only IVC stented 0 1
Iliocaval stenting 19 9
CFV stent 2 0
Note. DVT ¼ deep vein thrombosis; SFJ ¼ saphenofemoral junction;
SSV ¼ small saphenous vein; NIVL ¼ non-thrombotic iliac vein lesions14  120 mm stents, reﬂecting the preponderance of CIV
involvement and the smaller size of blood vessels in the
Indian subcontinent. Median stent length was 100 mm
(40e120 mm) and the median length of vein stented was
140 mm (60e260 mm).
Procedure-related complications included extravasation
of contrast due to presumed venous perforation in three
patients with venous occlusions. None of these events was
associated with hemodynamic instability, the need for blood
transfusions, or other clinical consequences.
Two access site hematomas were managed conserva-
tively. All patients were discharged the day after the
procedure.
Outcomes
Stent patency. Thirty-ﬁve limbs were assessed at 6-week, 3-
month, and annual follow-up appointments. Patients living
far from the hospital were advised to have a venous duplex
US carried out locally and to report the results. A median
follow-up of 15 months (1.5e28.0) was available for 35
limbs.
For calculation of the KaplaneMeir analysis of stent
patency, if any stent was found to be patent, it was
assumed to have been patent at all time points prior to this.
Venous Doppler at 6 weeks demonstrated one conﬁrmed
stent occlusion, which occurred within the ﬁrst 2 weeks.
Stents in the other 43 limbs remained patent. At 13 months,
one patient required reintervention for a new ulcer with
evidence of more caudad disease, which was successfully
treated by placing a further stent. The cumulative primary
and primary assisted patency at a median follow-up of 15
months were 94% and 97%, respectively.
Ulcer outcomes
At a median follow-up of 15 months, sustained ulcer healing
was achieved in 51% of limbs. The majority (58%) of these
ulcers had healed at 6 weeks. An ulcer healing rate of 60%
was achieved with the use of adjunctive procedures. Ulcer-ree status at 15 months.
o Ulcer persistence at 15 mo Impact on achieving
complete healing at 15 mo (p)
0 .169
2 .675
1 .918
1 .477
4 .015
2 .395
1 .970
5 .801
1 .801
1 .386
6 .174
2 .246
GSV ¼ great saphenous vein; SPJ ¼ saphenopopliteal junction;
; IVC ¼ inferior vena cava; CFV ¼ common femoral vein.
Figure 3. Ulcer healing outcomes among all limbs.
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Table 3, and the statistical analysis in Table 4. Fig. 3 shows
the proportions of ulcers achieving healing and Fig. 4 shows
the outcomes among ulcers once initial healing is achieved.
The presence of pre-procedure saphenopopliteal junction
or SSV reﬂux was the only factor found to have a signiﬁcant
impact on the achievement of ulcer healing (p ¼ .015), but
given the small numbers it is difﬁcult to be certain about its
clinical signiﬁcance.
Ulcer persistence. At 6 weeks, 11% of ulcers were un-
changed and 30% were reduced, but persistent. MedianFigure 4. Ulcer outcomes among limbs with healed ulcers.follow-up data at 15 months were available for 35 limbs. Of
these, 11% remained unchanged and 20% were reduced,
but persistent. Of this group, 73% had changes consistent
with post-thrombotic sequelae, and 27% had features sug-
gestive of NIVL.
Two patients were found to have new-onset segmental
superﬁcial reﬂuxdthey underwent endovenous laser abla-
tion of a reﬂuxing segment of the great saphenous vein. In
both limbs, the ulcer healed within 6 weeks of intervention.
Another patient underwent foam sclerotherapy of a short
saphenous vein, but the ulcer has persisted.
Another patient has a possible vasculitic component to a
very large ulcer. The ulcer has reduced by approximately
30% over 12 weeks.
Of note, among the three patients with NIVL and
persistent ulcers, signiﬁcant ulcer healing deﬁned as a
reduction in size of approximately 70e95% was achieved in
all. All three patients had very large conﬂuent ulcers
covering most of the lower leg. One of this group had had
an ulcer for 15 years with multiple local procedures carried
out, including skin grafts and failed ﬂaps. This patient had
originally approached the unit for an elective below-knee
amputation.
Ulcer recurrence. Of the healed ulcers, recurrences
occurred in six limbs within the ﬁrst 6 months. Three of
these ulcers have persisted. All ulcer recurrences have been
in patients with post-thrombotic damage.
Of the persistent recurrent ulcers, two were tiny ulcers in
a patient with bilateral disease. In the other limb, recur-
rence was associated with new onset postmenopausal
bleeding and suspected endometrial cancer. In both pa-
tients, the stents appeared patent with freedom from
restenosis on duplex US and CT venogram.
Three ulcers recurred and healed after interventions. One
ulcer healed after foam sclerotherapy of a dilated short
saphenous vein. Another ulcer appeared in association with
infection of an occluded cavo-femoral graft, which was
implanted 3 years before, and resolved after removal of the
graft. In one patient, ascending venogram demonstrated
additional disease in the common femoral vein. The
diseased area was stented with an 8-mm stent, and healing
was achieved within 2 weeks.DISCUSSION
Surgical interventions to treat venous ulcers have consisted
largely of procedures directed at the reﬂux pathology within
the superﬁcial venous system.4 Deep vein pathology has
been recognized as a risk factor for venous ulcers, especially
those that fail to heal after superﬁcial vein surgery. Much
effort had been directed towards deep vein valve recon-
struction, with good results.5,10
Since their development in the 1990s, endovascular in-
terventions for deep venous pathology have gained popu-
larity. The current trend of thrombolysis of iliofemoral DVT
is recognition of the likely role of deep vein obstruction in
the development of post-thrombotic syndrome.11,12
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bolysis to treat iliocaval occlusions, recognize the vital
importance of the iliocaval outﬂow segment in the devel-
opment of chronic venous insufﬁciency.
This series included patients from the Indian subconti-
nent, the Middle East, and Africa. This has posed challenges
in terms of maintaining follow-up.
Compared with other series, this one showed a complete
reversal of the sex ratio (female:male [F:M]1.0:2.1). Others
have reported F:M ratios of 4:1 or more, and female gender
has been identiﬁed to be a risk factor.6,10,13 This perhaps
reﬂects the unique socioeconomic nature of healthcare in
India, where women’s access to healthcare is notoriously
poorer than for men.14
The distribution of unilateral pathology in this series also
differs from other larger series. The left to right ratio was
1.4:1.0, which is different from that reported in the litera-
ture, where it ranges from 2.4:1.0 to 8.7:1.0.6,13 Perhaps
one reason for this difference could be the relatively smaller
proportion of NIVL lesions in this series compared with that
of Neglén et al.13
There is no access to intravascular US at the Narayana
Institute of Vascular Sciences. This tool has been described
as being the most accurate method of diagnosing and
treating deep vein obstructive lesions.15,16 A combination of
duplex US and CT venography has been relied upon to
select patients for an ascending venogram. In addition to
the usual techniques of obtaining views in more than one
plane, a trial ballooning was utilized to uncover hidden
lesions.
Unlike most other reports in the literature, in this study
Nitinol stents were used almost exclusively. The largest
experience (>1000 limbs) in venous stenting to date has
been reported.7,17,18 These studies used stainless steel
Wallstents (Boston Scientiﬁc-Schneider, Minneapolis, MN,
USA) for 98% of cases. Originally, Nitinol stents were used at
the Narayana Institute of Vascular Sciences because of the
lack of availability of Wallstents. The radial strength and
ﬂexibility of the E-Luminexx stent was soon appreciated. Its
availability in larger diameters and longer lengths make it
ideally suited to venous interventions. Bench testing has
previously shown that Nitinol stents have greater radial
resistive force than Wallstents.19 In addition, these stents
do not elongate and narrow at stenotic segments and thus
have a more predictable length.
One patient developed early stent thromboses. This pa-
tient had undergone a difﬁcult and prolonged procedure to
recanalize post-thrombotic occlusion of the CIV and EIV. The
literature also shows that the majority of stent occlusions
occur early,13,20,21 and especially in post-thrombotic limbs.14
Some authors have successfully lysed acutely occluded
stents and corrected the underlying problem, with a satis-
factory long-term outcome.13 Unfortunately, the patients in
this study were unwilling for the same.
In this study, the primary assisted patency rate of 97% is
similar to other large series reported.6,13,22
So far, one endovascular reintervention has been per-
formed, at 13 months, to achieve ulcer healing. This wasperhaps because the primary stents did not reach healthy
inﬂow or due to the development of ﬁbrosis caudad to the
stent. Other series have reported a median reintervention
time of 8 or 15 months, with a reintervention rate of
13%.6,12,20
In this series patients had a distribution ratio of NIVL
lesion:post-thrombotic lesion of 1.0:2.4. This is different
from the series of Neglén et al.,13 where a nearly equal
distribution between the two groups was found.
In this study, an ulcer healing rate of 51% was achieved at
15 months, which increased to 60% with the assistance of
additional procedures distant from the index stenting,
which is similar to other large series.14 Alhalbouni et al.23
also report a 58% ulcer healing rate with a median follow-
up of 3.6 months.
Among the 31% of ulcers that persisted three were
associated with NIVL lesions and had been expected to heal.
These three patients had very large and chronic ulcers, with
one patient previously having had multiple surgical pro-
cedures on the ulcer.
The ulcer healing rates in the post-thrombotic and NIVL
groups were similar (64% and 66%, respectively). This is
similar to the series reported by Neglén and Raju.13 The
healing rates in this study are inferior to those of Ye et al.,22
where a healing rate of 82% was achieved in a series of 205
patients (62 with ulcers) with NIVL.22
In this study, ulcer recurrence occurred in six limbs (17%).
Compared with the data of Neglén and Raju,13 this is un-
usual as their experience suggests that once ulcers heal
they stay healed. All recurrences in this study occurred in
the post-thrombotic group. Three of these recurrences
healed following an additional intervention, as detailed
above. A cause for ulcer recurrence in the remaining three
patients was not identiﬁed.CONCLUSION
Endovascular treatment of deep veins may be an effective
adjunctive treatment in the management of recalcitrant
venous ulcers. Using a combination of US, CT venography,
and ascending venography with trial ballooning, it is
possible to identify patients with deep vein disease. It is
important to have a high index of suspicion of deep vein
pathology, especially among patients with venous ulcers
without evidence of signiﬁcant superﬁcial reﬂux.
Ulcer recurrence should prompt a search for undiagnosed
or new onset deep or superﬁcial venous system pathology.
Some patients will need further interventions on either or
both the deep and superﬁcial systems.
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